Novavax (NVAX) to Report Q3 Earnings: What's in the Cards?

Mohit Chouhan November 02, 2021
On Novavax's (NVAX) upcoming third-quarter earnings call, investor focus is likely to be on the company's progress with its COVID-19 vaccine candidate NVX-CoV2373.


Post a Comment

0 Comments